Abstract

Background: Avoiding neuromuscular blocking drugs may prevent the potential complications of their use if they are not required for the planned procedure. This study was designed to estimate dose-response of propofol for tracheal intubation in children correlated to Intubation Condition Score and Cerebral State Index (CSI) without neuromuscular blocking drugs. Methods: 56 children (ages 3-8 years), ASA physical status I and II, weight 13-35 Kg, admitted for adenotonsillectomy were included. Children were randomly divided into four groups to receive propofol by Target Controlled Infusion (TCI) at different concentrations: 3.0 μg•ml-1, 3.5 μg•ml-1, 4.0 μg•ml-1, 4.5 μg•ml-1. At time T0 remifentanil infusion 0.5 μg•kg-1•min-1 was started. After 4 min, time T1, children received propofol according to their group. At time T2 (8 min after T0) tracheal intubation was carried out, Intubation Condition Score and CSI values at time T2 were assessed. Results: The results show that increasing propofol plasma concentrations from 3.0 μg•ml-1 to 4.5 μg•ml-1, the number of patients with acceptable intubating conditions, increased to 100%. There was a statistically significant difference with respect to Intubating Condition Score: 3.0 μg•ml-1 vs 4.5 μg•ml-1 and 3.0 μg•ml-1 vs 4.0 μg•ml-1. With reference to CSI values, a statistically significant difference was observed between 4.5 μg•ml-1 and the other 3 concentrations. We observed a significant difference in patients with CSI≤50 versus CSI>50 among the four propofol groups. Therefore, we detected a significant difference in the Intubation Condition Score between the CSI≤50 and CSI>50 groups. Conclusions: The administration of propofol at 4 and 4.5 μg•ml-1, coadministered with remifentanil 0.5 μg•kg-1•min-1, provided clinically acceptable conditions for tracheal intubation. In our opinion the use of CSI monitoring may be of practical value in producing acceptable intubating conditions in children.

Highlights

  • IntroductionTracheal intubation is commonly facilitated by the use of neuromuscular blocking drugs

  • After induction of anesthesia, tracheal intubation is commonly facilitated by the use of neuromuscular blocking drugs

  • In pediatric patients we studied the dose-response of different propofol concentrations by Target Controlled Infusion (TCI) [6,7] for tracheal intubation in children, co-administering 0.5 μgkg-1min-1 remifentanil and without neuromuscular blocking drugs

Read more

Summary

Introduction

Tracheal intubation is commonly facilitated by the use of neuromuscular blocking drugs. In pediatric patients we studied the dose-response of different propofol concentrations by Target Controlled Infusion (TCI) [6,7] for tracheal intubation in children, co-administering 0.5 μgkg-1min-1 remifentanil and without neuromuscular blocking drugs. For a better understanding of the degree of depth of anesthesia we used the Cerebral State Monitor (CSM) that is an EEG derived monitor (CSI TM, Danmeter, and Odense, Denmark). Avoiding neuromuscular blocking drugs may prevent the potential complications of their use if they are not required for the planned procedure. This study was designed to estimate dose-response of propofol for tracheal intubation in children correlated to Intubation Condition Score and Cerebral State Index (CSI) without neuromuscular blocking drugs

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.